Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2011 1
2013 3
2014 2
2015 2
2016 1
2017 1
2021 4
2022 7
2023 1
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Heterogeneous subpopulations of GABAAR-responding neurons coexist across neuronal network scales and developmental stages in health and disease.
Colombi I, Rastogi M, Parrini M, Alberti M, Potenzieri A, Chellali MM, Rosati S, Chiappalone M, Nanni M, Contestabile A, Cancedda L. Colombi I, et al. Among authors: rosati s. iScience. 2024 Mar 8;27(4):109438. doi: 10.1016/j.isci.2024.109438. eCollection 2024 Apr 19. iScience. 2024. PMID: 38544574 Free PMC article.
Early IGF-1 receptor inhibition in mice mimics preterm human brain disorders and reveals a therapeutic target.
Potenzieri A, Uccella S, Preiti D, Pisoni M, Rosati S, Lavarello C, Bartolucci M, Debellis D, Catalano F, Petretto A, Nobili L, Fellin T, Tucci V, Ramenghi LA, Savardi A, Cancedda L. Potenzieri A, et al. Among authors: rosati s. Sci Adv. 2024 Mar;10(9):eadk8123. doi: 10.1126/sciadv.adk8123. Epub 2024 Mar 1. Sci Adv. 2024. PMID: 38427732 Free PMC article.
Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection: prospective cohort study.
Mazzotta V, Lepri AC, Matusali G, Cimini E, Piselli P, Aguglia C, Lanini S, Colavita F, Notari S, Oliva A, Meschi S, Casetti R, Mondillo V, Vergori A, Bettini A, Grassi G, Pinnetti C, Lapa D, Tartaglia E, Gallì P, Mondi A, Montagnari G, Gagliardini R, Nicastri E, Lichtner M, Sarmati L, Tamburrini E, Mastroianni C, Stingone C, Siddu A, Barca A, Fontana C, Agrati C, Girardi E, Vaia F, Maggi F, Antinori A; Mpox Vaccine Lazio Study Group. Mazzotta V, et al. EClinicalMedicine. 2024 Jan 12;68:102420. doi: 10.1016/j.eclinm.2023.102420. eCollection 2024 Feb. EClinicalMedicine. 2024. PMID: 38292040 Free PMC article.
Telemedicine During COVID-19 Pandemic: Lesson Learned from the Lazio Region Infectious Diseases and Emergency Department Network.
Maffongelli G, Bevilacqua N, Vita S, Bartoli TA, Corpolongo A, Benvenuto D, Chiriaco T, Spiga G, Ribaldi S, Zirretta V, Ippolito G, Lauria FN, Vaia F, Nicastri E; COVID Group of the Lazio Region; Bed Manager Group at INMI Spallanzani. Maffongelli G, et al. J Med Syst. 2022 Dec 7;46(12):105. doi: 10.1007/s10916-022-01887-z. J Med Syst. 2022. PMID: 36473993 Free PMC article.
Viral load decrease in SARS-CoV-2 BA.1 and BA.2 Omicron sublineages infection after treatment with monoclonal antibodies and direct antiviral agents.
Mazzotta V, Cozzi Lepri A, Colavita F, Rosati S, Lalle E, Cimaglia C, Paulicelli J, Mastrorosa I, Vita S, Fabeni L, Vergori A, Maffongelli G, Carletti F, Lanini S, Caraffa E, Milozzi E, Libertone R, Piselli P, Girardi E, Garbuglia A, Vaia F, Maggi F, Nicastri E, Antinori A; INMI COVID-19 Outpatient Treatment Study Group. Mazzotta V, et al. Among authors: rosati s. J Med Virol. 2023 Jan;95(1):e28186. doi: 10.1002/jmv.28186. Epub 2022 Oct 7. J Med Virol. 2023. PMID: 36184918 Free PMC article.
SARS-CoV-2 nasopharyngeal viral load in individuals infected with BA.2, compared to Alpha, Gamma, Delta and BA.1 variants: A single-center comparative analysis.
Mastrorosa I, Cozzi-Lepri A, Colavita F, Lalle E, Mazzotta V, Cimaglia C, Paulicelli J, Matusali G, Fabeni L, Carletti F, Rosati S, Vita S, Giannico G, Piselli P, Biliotti E, Moghazi SA, Mosti S, Girardi E, Nicastri E, Garbuglia AR, Maggi F, Vaia F, Antinori A. Mastrorosa I, et al. Among authors: rosati s. J Clin Virol. 2022 Dec;157:105299. doi: 10.1016/j.jcv.2022.105299. Epub 2022 Sep 26. J Clin Virol. 2022. PMID: 36183546 Free PMC article.
Clinical Management of Patients With B-Cell Depletion Agents to Treat or Prevent Prolonged and Severe SARS-COV-2 Infection: Defining a Treatment Pathway.
D'Abramo A, Vita S, Maffongelli G, Beccacece A, Agrati C, Cimini E, Colavita F, Giancola ML, Cavasio A, Nicastri E; Spallanzani COVID-19 Case Investigation Team. D'Abramo A, et al. Front Immunol. 2022 May 27;13:911339. doi: 10.3389/fimmu.2022.911339. eCollection 2022. Front Immunol. 2022. PMID: 35711444 Free PMC article.
Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022.
Antinori A, Mazzotta V, Vita S, Carletti F, Tacconi D, Lapini LE, D'Abramo A, Cicalini S, Lapa D, Pittalis S, Puro V, Rivano Capparuccia M, Giombini E, Gruber CEM, Garbuglia AR, Marani A, Vairo F, Girardi E, Vaia F, Nicastri E; INMI Monkeypox Group. Antinori A, et al. Euro Surveill. 2022 Jun;27(22):2200421. doi: 10.2807/1560-7917.ES.2022.27.22.2200421. Euro Surveill. 2022. PMID: 35656836 Free PMC article.
Emulation of a Target Trial From Observational Data to Compare Effectiveness of Casirivimab/Imdevimab and Bamlanivimab/Etesevimab for Early Treatment of Non-Hospitalized Patients With COVID-19.
Mazzotta V, Cozzi-Lepri A, Colavita F, Lanini S, Rosati S, Lalle E, Mastrorosa I, Cimaglia C, Vergori A, Bevilacqua N, Lapa D, Mariano A, Bettini A, Agrati C, Piselli P, Girardi E, Castilletti C, Garbuglia AR, Vaia F, Nicastri E, Antinori A. Mazzotta V, et al. Among authors: rosati s. Front Immunol. 2022 Apr 20;13:868020. doi: 10.3389/fimmu.2022.868020. eCollection 2022. Front Immunol. 2022. PMID: 35514955 Free PMC article. Clinical Trial.
26 results